surgalign holdings, inc., a medical technology company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. it offers coflex interlaminar stabilization device, an implant for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; simmetry sacroiliac joint fusion system, which decreases in opioid use, pain, and disability; and fortilink ibf system with tetrafuse ?3d technology. the company's implants are used in the fields of orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. it markets its products through its direct distribution force and various oem relationships to healthcare providers, hospitals, and other healthcare facilities, as well as through a network of independent distributors. the company was founded in 1997 and is headquartered in dee
Company profile
Ticker
SRGAQ
Exchange
Website
CEO
Terry M. Rich
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Align Technology • RTI Surgical ...
Former names
Bears Holding Sub, Inc., RTI Surgical Holdings, Inc.
SEC CIK
Corporate docs
Subsidiaries
Surgalign Spine Technologies, Inc. • RTI Services, Inc. • Tutogen Medical, Inc. • Pioneer Surgical Technology, Inc. • Angstrom Acquisition Corp. • Pioneer Surgical Orthobiologics, Inc. • Zyga Technology, Inc. • Paradigm Spine LLC • Andi’s Belmarall, LLC • Fourth Dimension Spine, LLC ...
IRS number
832540607
SRGAQ stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
13 Nov 23
EFFECT
Notice of effectiveness
10 Oct 23
EFFECT
Notice of effectiveness
10 Oct 23
EFFECT
Notice of effectiveness
6 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Oct 23
POS AM
Prospectus update (post-effective amendment)
2 Oct 23
POS AM
Prospectus update (post-effective amendment)
2 Oct 23
POS AM
Prospectus update (post-effective amendment)
2 Oct 23
Transcripts
SRGAQ
Earnings call transcript
2023 Q1
11 May 23
SRGAQ
Earnings call transcript
2022 Q4
30 Mar 23
SRGAQ
Earnings call transcript
2022 Q3
3 Nov 22
SRGAQ
Earnings call transcript
2022 Q2
10 Aug 22
SRGAQ
Earnings call transcript
2022 Q1
11 May 22
SRGAQ
Earnings call transcript
2021 Q4
16 Mar 22
SRGAQ
Earnings call transcript
2021 Q3
10 Nov 21
SRGAQ
Earnings call transcript
2021 Q2
6 Aug 21
SRGAQ
Earnings call transcript
2021 Q1
11 May 21
SRGAQ
Earnings call transcript
2020 Q4
17 Mar 21
Latest ownership filings
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 22.43 mm | 22.43 mm | 22.43 mm | 22.43 mm | 22.43 mm | 22.43 mm |
Cash burn (monthly) | (no burn) | 1.85 mm | (no burn) | 5.59 mm | 3.01 mm | 3.50 mm |
Cash used (since last report) | n/a | 22.10 mm | n/a | 66.61 mm | 35.85 mm | 41.71 mm |
Cash remaining | n/a | 332.14 k | n/a | -44.18 mm | -13.42 mm | -19.28 mm |
Runway (months of cash) | n/a | 0.2 | n/a | -7.9 | -4.5 | -5.5 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 26 |
Opened positions | 4 |
Closed positions | 15 |
Increased positions | 5 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 102.34 mm |
Total shares | 10.10 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Roboticine | 6.25 mm | $10.63 mm |
Glen Capital Partners Focus Fund | 3.24 mm | $7.10 mm |
HRT Financial | 96.53 k | $17.00 k |
Raymond James Financial Services Advisors | 91.69 k | $16.77 mm |
Cerity Partners | 77.39 k | $14.15 mm |
UBS UBS Group AG - Registered Shares | 49.91 k | $9.13 mm |
Cubist Systematic Strategies | 48.76 k | $8.92 mm |
VIRT Virtu Financial | 40.66 k | $7.00 k |
Koss-Olinger Consulting | 35.28 k | $6.00 mm |
Jane Street | 35.08 k | $6.42 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Sep 23 | Lyle David | Common Stock | Payment of exercise | Dispose F | No | No | 0.01 | 1,329 | 13.29 | 83,307 |
1 Sep 23 | Paolo Amoruso | Common Stock | Payment of exercise | Dispose F | No | No | 0.01 | 2,191 | 21.91 | 28,809 |
15 Aug 23 | Lyle David | Common Stock | Payment of exercise | Dispose F | No | No | 0.02 | 8,072 | 161.44 | 84,636 |
15 Aug 23 | Marc E. Mackey | Common Stock | Payment of exercise | Dispose F | No | No | 0.02 | 4,589 | 91.78 | 44,280 |
15 Aug 23 | Terry M. Rich | Common Stock | Payment of exercise | Dispose F | No | No | 0.02 | 8,821 | 176.42 | 149,683 |